These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9026655)

  • 21. Inhibition of HIV-1 reverse transcriptase-catalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid.
    Davis WR; Tomsho J; Nikam S; Cook EM; Somand D; Peliska JA
    Biochemistry; 2000 Nov; 39(46):14279-91. PubMed ID: 11087377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory RNA ligand to reverse transcriptase from feline immunodeficiency virus.
    Chen H; McBroom DG; Zhu YQ; Gold L; North TW
    Biochemistry; 1996 May; 35(21):6923-30. PubMed ID: 8639644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active site binding and sequence requirements for inhibition of HIV-1 reverse transcriptase by the RT1 family of single-stranded DNA aptamers.
    Kissel JD; Held DM; Hardy RW; Burke DH
    Nucleic Acids Res; 2007; 35(15):5039-50. PubMed ID: 17644816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.
    Loya S; Rudi A; Kashman Y; Hizi A
    Biochem J; 2002 Mar; 362(Pt 3):685-92. PubMed ID: 11879196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substitution of conserved hydrophobic residues in motifs B and C of HIV-1 RT alters the geometry of its catalytic pocket.
    Sharma B; Kaushik N; Singh K; Kumar S; Pandey VN
    Biochemistry; 2002 Dec; 41(52):15685-97. PubMed ID: 12501197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the reverse transcriptase of human immunodeficiency virus type 1 by dNTPs.
    West AB; Roberts TM; Kolodner RD
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9720-4. PubMed ID: 1384060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
    Ueno T; Mitsuya H
    Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA.
    Peletskaya EN; Kogon AA; Tuske S; Arnold E; Hughes SH
    J Virol; 2004 Apr; 78(7):3387-97. PubMed ID: 15016861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: mispair extension frequencies.
    Bakhanashvili M; Hizi A
    Biochemistry; 1992 Oct; 31(39):9393-8. PubMed ID: 1382590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
    Oz Gleenberg I; Herschhorn A; Goldgur Y; Hizi A
    Arch Biochem Biophys; 2007 Feb; 458(2):202-12. PubMed ID: 17257575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interaction of primers with mutant forms of human immunodeficiency virus reverse transcriptase].
    Zakharova OD; Suturina OA; Gudima SO; Pokholok DK; Iamkovoĭ VI; Kochetkov SN; Nevinskiĭ GA
    Mol Biol (Mosk); 1996; 30(1):231-40. PubMed ID: 8714140
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of HIV-1 reverse transcriptase with modified oligonucleotide primers containing 2'-O-beta-D-ribofuranosyladenosine.
    Golubeva AS; Ermolinsky BS; Efimtseva EV; Tunitskaya VL; van Aerschot A; Herdewijn P; Mikhailov SN; Kochetkov SN
    Biochemistry (Mosc); 2004 Feb; 69(2):130-6. PubMed ID: 15000678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of nonnucleoside HIV reverse transcriptase inhibitors.
    Tucker TJ; Lumma WC; Culberson JC
    Methods Enzymol; 1996; 275():440-72. PubMed ID: 9026654
    [No Abstract]   [Full Text] [Related]  

  • 37. N-3 substituted TSAO derivatives as a probe to explore the dimeric interface of HIV-1 reverse transcriptase.
    Bonache MC; Chamorro C; Velázquez S; De Clercq E; Balzarini J; Camarasa MJ; San-Félix A
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):947-9. PubMed ID: 14565318
    [No Abstract]   [Full Text] [Related]  

  • 38. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
    Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviral reverse transcriptases.
    Herschhorn A; Hizi A
    Cell Mol Life Sci; 2010 Aug; 67(16):2717-47. PubMed ID: 20358252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase.
    Le Grice SF; Cameron CE; Benkovic SJ
    Methods Enzymol; 1995; 262():130-44. PubMed ID: 8594344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.